In order to assess the involvement of CS/DS, IGF-1, and IGFBP-3 metabolism in the inflammation, we estimated the relationships between circulating levels of these parameters and inflammatory markers i.e., CRP and ESR, in patients with JIA, both before treatment and after clinical improvement resulting from the applied therapy (Table 6). This evidence concerns the gene IGF1 and juvenile idiopathic arthritis.